Coeptis Therapeutics Announces Phase 1 Data on DVX201 for COVID-19 Treatment Has Been Accepted for Publication in Molecular Therapy Methods and Clinical Development ...Middle East

Study results demonstrate the safety and feasibility of adoptive immunotherapy using allogeneic off-the-shelf NK cells in hospitalized patients with COVID at high risk for progression of disease DVX201, the first allogeneic NK cell therapy derived from pooled donor cord blood CD34+ cells,...

Read More Details
Finally We wish PressBee provided you with enough information of ( Coeptis Therapeutics Announces Phase 1 Data on DVX201 for COVID-19 Treatment Has Been Accepted for Publication in Molecular Therapy Methods and Clinical Development )

Also on site :

• Trump’s attack on diversity takes center stage as Boston remembers 1965 Freedom Rally led by MLK
• Pacifica graduate Nohl Williams drafted in 3rd round by the Kansas City Chiefs
• Lana Del Rey Sings About Kissing Morgan Wallen, Covers Tammy Wynette and John Denver, and Goes Swinging in Unpredictable Stagecoach Set